Double Blind, Placebo-controlled, Dose Finding, Prospective, Multicenter Clinical Trial for the Treatment of Rhinitis/Rhinoconjunctivitis Against a Mixture of Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs MM 09 (Primary)
- Indications Hypersensitivity
- Focus Therapeutic Use
- Sponsors Inmunotek
- 02 Mar 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2018.
- 02 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 02 Mar 2017 Status changed from not yet recruiting to recruiting.